Latest Health News

Page 170 of 171
Wesfarmers has announced the wind down of Catch as a standalone business, transferring its e-commerce fulfilment centres to Kmart Group and integrating key digital capabilities into its retail divisions to strengthen omnichannel offerings.
Logan Eniac
Logan Eniac
21 Jan 2025
Korvest Ltd has announced a fully franked ordinary dividend of AUD 0.25 per share for the six months ending December 2024, signaling steady shareholder returns.
Victor Sage
Victor Sage
20 Jan 2025
Immuron Limited reports a striking 70% quarter-on-quarter increase in Travelan® sales, driven by expanded pharmacy distribution in Australia and North America.
Victor Sage
Victor Sage
17 Jan 2025
Visioneering Technologies reports promising interim results from its PROTECT trial, showing significant control of myopia progression in children using NaturalVue® Multifocal lenses.
Ada Torres
Ada Torres
16 Jan 2025
Pro Medicus has secured a $33 million, nine-year contract to implement its Visage 7 cloud-based imaging platform across the University of Kentucky’s health system, marking a significant expansion in North American academic healthcare.
Ada Torres
Ada Torres
16 Jan 2025
Memphasys Limited has secured a major scientific endorsement for its RoXsta™ antioxidant profiling system, positioning the technology for expanded clinical and agricultural applications.
Ada Torres
Ada Torres
16 Jan 2025
Genesis Minerals Limited reported a record December quarter gold production of 57,055oz, driven by an accelerated Laverton mill restart and strong operational execution. The company’s cash reserves surged 34% to A$238 million, underpinning its debt-free growth strategy.
Maxwell Dee
Maxwell Dee
16 Jan 2025
Orthocell Limited has reported a third consecutive quarter of record revenue, driven by strong sales growth and strategic market expansions, including a key US FDA submission for its nerve repair product Remplir™.
Ada Torres
Ada Torres
15 Jan 2025
Anatara Lifesciences has successfully completed recruitment for the second stage of its pivotal GaRP-IBS clinical trial, with headline results expected in Q1 2025. The company also launched a new anti-obesity project and strengthened its cash position through recent capital raises.
Ada Torres
Ada Torres
15 Jan 2025
HITIQ Limited has received $1.6 million from the R&D Tax Incentive Scheme, using most of it to repay its RDTI Facility with Keystone Capital Partners, signaling a strategic move to streamline its R&D funding.
Sophie Babbage
Sophie Babbage
14 Jan 2025
Immuron has submitted its Phase 2 clinical study report for Travelan® to the FDA, revealing statistically significant immunological and microbiome benefits. The company is preparing to engage the FDA for Phase 3 trial discussions while progressing a large field study with military personnel.
Ada Torres
Ada Torres
14 Jan 2025
Way 2 Vat Ltd's trading suspension is scheduled to end on 13 January 2025, coinciding with the announcement of a proposed capital raising that could reshape its financial outlook.
Claire Turing
Claire Turing
13 Jan 2025